Neuroendocrine Tumor — Trials

Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

805 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04140409	Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation(SCIROCCO)	terminated	Phase 4	10	Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER	0	Oct 25, 2019	clinicaltrials

Data updated 22 days agoSource updated Oct 25, 2019source: clinicaltrials